Investigating the simultaneous effect of Phototherapy with oral Zinc Sulfate on the amount of Bilirubin change in infants with Hyperbilirubinemia and the duration of their treatment in Baharlou Hospital.

Phase 2

Recruiting

• Conditions: Congenital Jaundice.; Neonatal jaundice from other and unspecified causes

• Registration Number: IRCT20230914059430N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 March 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 320

Inclusion Criteria

All full-term babies without risk factors born with Neonatal Jaundice

Exclusion Criteria

Lack of parental consent
The presence of major risk factors in the baby, including Cardiovascular, Pulmonary, Renal defects, etc.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Total Bilirubin. Timepoint: Measurement of serum total bilirubin level at the beginning of the study (before the start of the intervention), 2 and 14 days after the start of oral zinc sulfate intake. Method of measurement: Blood examination.;Zinc Sulfate level in serum. Timepoint: Immediately before and after phototherapy depending on the duration of phototherapy. Method of measurement: Blood examination.

Secondary Outcome Measures

Name	Time	Method
The duration of receiving phototherapy. Timepoint: Up to 14 days after the study. Method of measurement: Medical record.;The length of hospitalization. Timepoint: Up to 14 days after the study. Method of measurement: Medical record.